PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders
出版年份 2023 全文链接
标题
PROTAC derivatization of natural products for target identification and drug discovery: Design of evodiamine-based PROTACs as novel REXO4 degraders
作者
关键词
-
出版物
Journal of Advanced Research
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-11-01
DOI
10.1016/j.jare.2023.10.014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity
- (2023) Xiao-Meng Liu et al. Journal of Medicinal Chemistry
- Strategies for designing proteolysis targeting chimaeras (PROTACs)
- (2022) Shipeng He et al. MEDICINAL RESEARCH REVIEWS
- An update of label-free protein target identification methods for natural active products
- (2022) Zhao Cui et al. Theranostics
- Discovery of novel bis-evodiamine derivatives with potent antitumor activity
- (2022) Huixin Liang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives as Potential Antihepatocellular Carcinoma Agents
- (2022) Fang Lei et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC technology as a novel tool to identify the target of lathyrane diterpenoids
- (2022) Yanli Wu et al. Acta Pharmaceutica Sinica B
- Recent Advances in PROTACs for Drug Targeted Protein Research
- (2022) Tingting Yao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug discovery inspired by bioactive small molecules from nature
- (2022) Seyun Kim et al. Animal Cells and Systems
- Making Protein Degradation Visible: Discovery of Theranostic PROTACs for Detecting and Degrading NAMPT
- (2022) Junfei Cheng et al. Journal of Medicinal Chemistry
- Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents
- (2021) Zonglin Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aptamer–PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
- (2021) Shipeng He et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma
- (2021) Xiaohong Fan et al. BIOORGANIC CHEMISTRY
- Water-soluble derivatives of evodiamine: Discovery of evodiamine-10-phosphate as an orally active antitumor lead compound
- (2021) Shuqiang Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The expression and prognostic value of REXO4 in hepatocellular carcinoma
- (2021) Weipeng Chen et al. Journal of Gastrointestinal Oncology
- Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer
- (2021) Shengtao Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Synthesis, Structural Modification and Mode of Anticancer Action of Evodiamine: a review
- (2021) Meixia Fan et al. Recent Patents on Anti-Cancer Drug Discovery
- NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
- (2021) Ying Wu et al. Acta Pharmaceutica Sinica B
- REXO4 acts as a biomarker and promotes hepatocellular carcinoma progression
- (2021) Yun Ruan et al. Journal of Gastrointestinal Oncology
- Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
- (2020) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Discovery of Novel PDEδ Degraders for the Treatment of KRAS Mutant Colorectal Cancer
- (2020) Junfei Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Network Analysis of miRNA and mRNA Changes in the Prelimbic Cortex of Rats With Chronic Neuropathic Pain: Pointing to Inflammation
- (2020) Guohong Cai et al. Frontiers in Genetics
- Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
- (2020) Shenxin Zeng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Homo-PROTAC mediated suicide of MDM2 to treat non-small cell lung cancer
- (2020) Shipeng He et al. Acta Pharmaceutica Sinica B
- Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
- (2019) Yahui Huang et al. Acta Pharmaceutica Sinica B
- Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer
- (2019) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties
- (2018) Xu Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
- (2018) Jinlei Bian et al. BIOORGANIC CHEMISTRY
- Recent advances in target identification of bioactive natural products
- (2018) Minoru Yoshida BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The structural modification of natural products for novel drug discovery
- (2016) Hong Yao et al. Expert Opinion on Drug Discovery
- Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
- (2016) Jonathan B. Baell JOURNAL OF NATURAL PRODUCTS
- Target identification of natural products and bioactive compounds using affinity-based probes
- (2016) Sijun Pan et al. NATURAL PRODUCT REPORTS
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells
- (2015) Nirmala Krishnamurthy et al. CANCER BIOLOGY & THERAPY
- Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents
- (2015) Shengzheng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prime time for PROTACs
- (2015) Raymond J Deshaies Nature Chemical Biology
- Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
- (2015) Shipeng He et al. ACS Medicinal Chemistry Letters
- Oxidative stress and autophagy: the clash between damage and metabolic needs
- (2014) G Filomeni et al. CELL DEATH AND DIFFERENTIATION
- Chemo- and site-selective derivatizations of natural products enabling biological studies
- (2014) Omar Robles et al. NATURAL PRODUCT REPORTS
- Natural product and natural product derived drugs in clinical trials
- (2014) Mark S. Butler et al. NATURAL PRODUCT REPORTS
- The discovery of first-in-class drugs: origins and evolution
- (2014) Jörg Eder et al. NATURE REVIEWS DRUG DISCOVERY
- Phenotypic screening in cancer drug discovery — past, present and future
- (2014) John G. Moffat et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacological Actions of Multi-Target-Directed Evodiamine
- (2013) Hui Yu et al. MOLECULES
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
- (2012) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites
- (2011) N Krishnamurthy et al. ONCOGENE
- Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents
- (2010) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- Development of an Aryl Hydrocarbon Receptor Antagonist Using the Proteolysis-Targeting Chimeric Molecules Approach: A Potential Tool for Chemoprevention
- (2008) D. Puppala et al. MOLECULAR PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now